Global Bio-chem Technology's (HKG:0809) attributable profit fell to HK$769.6 million in 2024 from HK$4.22 billion in 2023, according to an annual report filed Wednesday with the Hong Kong bourse.
Earnings per share at the biotechnology firm increased to HK$0.029 from HK$0.291 in the previous year.
Revenue grew to HK$2 billion from HK$1.37 billion a year earlier.